Cellebrite Reports Third-Quarter 2026 Results
FROM THE WIRE · PRNEWSWIRE.COM
Third-Quarter ARR Growth of 20% and TTM Free Cash Flow Margin of 31% Net income of $26.7 million; Non-GAAP net income of $45.6 million and adjusted EBITDA of $53.6 million, 36% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 12, 2026 /PRNewswire/…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishResults show 20% ARR growth and a 36% adjusted EBITDA margin, which are relevant for the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Third-quarter ARR growth was 20%.
- 02The TTM free cash flow margin was 31%.
- 03Net income was $26.7 million and adjusted EBITDA was $53.6 million.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets